Finn, Richard S.; Galle, Peter R.; Ducreux, Michel et al.
Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma with Main Trunk and/or Contralateral Portal Vein Invasion in IMbrave150LIVER CANCER. Bd. 13. H. 6. 2024 S. 655-668
Stern, Louisa; Schmidt, Constantin; Kocheise, Lorenz et al.
Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinomaANNALS OF HEPATOLOGY. Bd. 29. H. 6. 2024
Weiss, Lena; Stintzing, Sebastian; Modest, Dominik Paul et al.
Efficacy of FOLFIRI plus bevacizumab versus FOLFIRI plus cetuximab in RAS-mutant metastatic colorectal cancer: Final update on patients with RAS-mutant metastatic colorectal cancer treated in FIRE-3JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 16. 2024
Mitzlaff, Katharina; Kirstein, Martha M.; Mueller, Christian et al.
Efficacy, safety and differential outcomes of immune-chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohortUNITED EUROPEAN GASTROENTEROLOGY JOURNAL. Bd. 12. H. 9. 2024 S. 1230-1242
Kroese, Tiuri E.; Bronzwaer, Sebastiaan; van Rossum, Peter S. N. et al.
European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4)EUROPEAN JOURNAL OF CANCER. Bd. 204. 2024
Daza, Jimmy; Bezerra, Lucas; Bantel, Heike et al.
Evaluation of four chatbots in autoimmune liver disease: a comparative analysisJOURNAL OF HEPATOLOGY. Bd. 80. 2024 S. S334-S334
Kremer, Wolfgang Maximilian; Schwarz, Alexander; Schepers, Markus et al.
Evaluation of Sonographic Muscle Measurement Using Established Muscle MarkersJOURNAL OF ULTRASOUND IN MEDICINE. Bd. 43. H. 12. 2024 S. 2385-2397
Reig, Maria; Forner, Alejandro; Rimola, Jordi et al.
Evidence and choice: The BCLC vision for tailoring clinical decision-makingJOURNAL OF HEPATOLOGY. Bd. 81. H. 4. 2024 S. e176-e177
Nikolopoulos, Dionysis; Lourenco, Maria Helena; Depascale, Roberto et al.
Evolving Concepts in Treat-to-Target Strategies for Systemic Lupus ErythematosusMEDITERRANEAN JOURNAL OF RHEUMATOLOGY. Bd. 35. H. 2. 2024
Janjigian, Yelena Y.; Ajani, Jaffer A.; Moehler, Markus et al.
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 TrialJOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 17. 2024